Skip to main content

Jeffrey Wolf

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeffrey Wolf

Jeffrey Wolf is recorded as Board Member at Theriva Biologics, Inc. (TOVX). Theriva Biologics, Inc. reported in an 8-K filed August 4, 2026 that Jeffrey Wolf was appointed Director, effective August 3, 2026. Theriva Biologics, Inc. reported in an 8-K filed September 4, 2025 that Jeffrey Wolf was appointed Director, effective August 29, 2025. Theriva Biologics, Inc. reported in an 8-K filed November 1, 2024 that Jeffrey Wolf was appointed director, effective October 31, 2024. Equibles holds 4 filed executive changes naming Jeffrey Wolf; each is listed under recent activity with its source filing.

“The following four (4) individuals were elected as directors, to serve until the Company’s next annual meeting of stockholders and until their respective successors have been duly elected and qualified with the following votes:”
Theriva Biologics, Inc. Form 8-K, filed August 4, 2026 · Read the filing
“The following four (4) individuals were elected as directors, to serve until the Company's next annual meeting of stockholders and until their respective successors have been duly elected and qualified with the following votes:”
Theriva Biologics, Inc. Form 8-K, filed September 4, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Organization not stated

    Board Member

    Proxy statement

    Current

    2008-01-01–present

  • Theriva Biologics, Inc. (TOVX)

    Board Member

    Proxy statement

    Current

    2006-01-01–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Company

Current role

Board Member

2008-01-01–present

Leadership on record at Theriva Biologics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.